U.S. Physical Therapy reaffirms $102M-$106M adjusted EBITDA guidance as NYU Langone rollout expands into Q3 (NYSE:USPH)
· seekingalpha.com
USPH Q2 2026 earnings call recap: record visit volumes, reimbursement gains, margin headwinds, and reaffirmed $102–$106M EBITDA guidance—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...